Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).
Ruwandi M KariyawasamDanielle A JulienDana C JelinskiSamantha L LaroseElissa Rennert-MayJohn M ConlyTanis C DingleJustin Z ChenGregory J TyrrellPaul E RonksleyHerman W BarkemaPublished in: Antimicrobial resistance and infection control (2022)
During the first 18 months of the pandemic, AMR prevalence was high in COVID-19 patients and varied by hospital and geography although there was substantial heterogeneity. Given the variation in patient populations within these studies, clinical settings, practice patterns, and definitions of AMR, further research is warranted to quantify AMR in COVID-19 patients to improve surveillance programs, infection prevention and control practices and antimicrobial stewardship programs globally.